Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (TSE:MRMD)
:MRMD
Earnings Data
Report Date
May 13, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.01Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a cautiously optimistic tone: MariMed reported continued brand and wholesale momentum (category leadership, expanded penetration, wholesale growth, Delaware AU traction), maintained positive adjusted EBITDA streak, and executed balance sheet actions to improve flexibility. However, the company is facing notable margin and retail headwinds in mature markets (notably Illinois and Massachusetts), experienced declines in EBITDA and operating income YoY, and has limited near‑term cash reserves. Management emphasized disciplined cost control, asset‑light licensing expansion, and selective M&A, while acknowledging timing risk for new market contributions.Company Guidance
Full‑Year Revenue and Reported Growth
Reported full‑year revenue of approximately $159.8–$160.0 million for FY2025, with management describing modest year‑over‑year growth (Jon referenced ~1% YoY while the CFO noted ~7% YoY); Q4 revenue was $41.7 million with 1.3% sequential growth in the quarter.
Positive Adjusted EBITDA Streak
Sixth consecutive year of positive adjusted EBITDA. FY2025 non‑GAAP EBITDA was $16.9 million representing a 10.5% EBITDA margin.
Wholesale Channel Expansion
Aggregate wholesale revenue grew 11% in 2025 and now represents 44% of total revenue (up from 40% in 2024). Wholesale momentum included strong entries into new markets (e.g., Illinois, Delaware).
Retail Momentum and Loyalty Program
Retail sequential growth of 4% in Q4 2025 (versus a 5% decline in the comparable prior quarter), transactions increased 4% sequentially and 8% YoY. Thrive loyalty membership grew 7% sequentially and 31% YoY; company launched a Thrive retail app to drive personalized communications and lower costs.
Market Share Leadership in Key Categories and Delaware AU Launch
Brands showed category leadership: Betty's Eddies was #1 edible in available markets; Vibations ranked #4 in RTD beverage mix. Following Delaware adult‑use launch, wholesale revenue in Delaware rose 37% sequentially and management reports #1 overall market share in the state across multiple brands and categories; retail sales across the two Delaware stores increased ~1.25x post adult‑use transition.
Rapid Scale in Illinois Wholesale
In Illinois (distribution started two years prior), wholesale revenue increased 39% YoY and company expanded into 27 additional dispensaries, finishing the year with ~82% penetration in that state.
High Penetration Across Core Markets
Company sold into ~85% of retail stores across its markets (penetration up ~200 basis points). Massachusetts penetration reached ~83% of dispensaries (a 4% increase vs 2024); Maryland penetration nearly 100% (108/109 dispensaries).
Expense Discipline and Liquidity Actions
Total operating expenses increased only ~0.7% YoY, reflecting disciplined SG&A. Completed restructuring of preferred shares to extend maturities and improve flexibility. Cash and cash equivalents increased to $8.9 million from $7.3 million at FY2024 close; no material debt maturities near term.
TSE:MRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:MRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | C$0.16 | C$0.14 | -12.50% |
Aug 06, 2025 | C$0.15 | C$0.14 | -6.67% |
May 07, 2025 | C$0.14 | C$0.14 | -6.90% |
Mar 05, 2025 | C$0.17 | C$0.17 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does MariMed Inc (TSE:MRMD) report earnings?
MariMed Inc (TSE:MRMD) is schdueled to report earning on May 13, 2026, TBA (Confirmed).
What is MariMed Inc (TSE:MRMD) earnings time?
MariMed Inc (TSE:MRMD) earnings time is at May 13, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:MRMD EPS forecast?
TSE:MRMD EPS forecast for the fiscal quarter 2026 (Q1) is -0.01.